Insider Trading & Ownership - REESE DAVID M

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for REESE DAVID M

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-07
Option Award
2024-05-09
7:07 pm
2026-05-07
2034-05-07
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
20,767$300.382,656
(Direct)
View
2024-05-07
Option Award
2024-05-09
7:07 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
3,196$082,656
(Direct)
View
2024-05-05
Tax Withholding
2024-05-07
8:37 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
633$311.2958,693
(Direct)
View
2024-05-02
Tax Withholding
2024-05-03
7:24 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
650$277.3759,326
(Direct)
View
2024-04-30
Tax Withholding
2024-05-01
7:54 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
690$276.3859,976
(Direct)
View
2024-03-18
Tax Withholding
2024-03-20
8:11 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
6,202$268.8760,666
(Direct)
View
2024-03-06
Option Award
2024-03-08
5:32 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP & Chief Technology Officer
12,407$066,653
(Direct)
View
2023-11-28
Gift
2023-11-29
8:44 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
165$054,164
(Direct)
View
2023-05-05
Tax Withholding
2023-05-09
7:24 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
594$231.8954,114
(Direct)
View
2023-05-03
Tax Withholding
2023-05-04
8:32 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
819$235.9786,958
(Direct)
View
2023-05-02
Option Award
2023-05-04
8:32 pm
2025-05-02
2033-05-02
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
36,064$086,958
(Direct)
View
2023-04-30
Tax Withholding
2023-05-02
8:28 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
666$239.7451,713
(Direct)
View
2023-03-17
Tax Withholding
2023-03-20
7:14 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
3,978$234.5752,379
(Direct)
View
2023-03-06
Option Award
2023-03-08
7:04 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
7,947$056,167
(Direct)
View
2022-11-02
Tax Withholding
2022-11-03
9:38 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,440$272.0648,136
(Direct)
View
2022-05-05
Tax Withholding
2022-05-09
7:12 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
575$236.150,307
(Direct)
View
2022-05-03
Tax Withholding
2022-05-04
8:07 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
770$230.9282,699
(Direct)
View
2022-05-02
Option Award
2022-05-04
8:07 pm
2024-05-02
2032-05-02
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
35,714$082,699
(Direct)
View
2022-04-27
Tax Withholding
2022-04-29
6:47 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
184$249.8747,755
(Direct)
View
2022-03-18
Tax Withholding
2022-03-22
5:47 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
4,995$235.8647,939
(Direct)
View
2022-03-01
Option Award
2022-03-03
7:33 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
9,989$052,714
(Direct)
View
2021-11-02
Tax Withholding
2021-11-03
7:27 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,192$209.7442,593
(Direct)
View
2021-05-01
Tax Withholding
2021-05-04
7:41 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,854$239.6479,254
(Direct)
View
2021-04-30
Option Award
2021-05-04
7:41 pm
2023-04-30
2031-04-30
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
38,788$079,254
(Direct)
View
2021-04-27
Tax Withholding
2021-04-28
8:17 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
174$255.5242,320
(Direct)
View
2021-03-19
Tax Withholding
2021-03-22
6:34 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,401$244.4242,494
(Direct)
View
2021-03-02
Option Award
2021-03-04
8:35 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,803$043,715
(Direct)
View
2021-02-16
Exercise
2021-02-16
8:59 pm
2013-04-25
2021-04-25
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,300$040,912
(Direct)
View
2021-02-16
Tax Withholding
2021-02-16
8:59 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,147$237.2140,912
(Direct)
View
2021-02-16
Exercise
2021-02-16
8:59 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,300$54.6940,912
(Direct)
View
2020-11-02
Tax Withholding
2020-11-04
7:06 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
2,125$216.9439,619
(Direct)
View
2020-05-05
Option Award
2020-05-07
9:04 pm
2022-05-05
2030-05-05
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
32,519$070,458
(Direct)
View
2020-05-01
Tax Withholding
2020-05-05
7:57 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,046$239.2237,939
(Direct)
View
2020-05-03
Tax Withholding
2020-05-05
7:57 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
185$230.9837,939
(Direct)
View
2020-04-27
Tax Withholding
2020-04-29
7:04 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
168$236.2839,170
(Direct)
View
2020-03-20
Tax Withholding
2020-03-24
6:09 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,855$198.7639,338
(Direct)
View
2020-03-09
Exercise
2020-03-10
9:12 pm
2012-04-26
2020-04-26
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,480$040,985
(Direct)
View
2020-03-09
Tax Withholding
2020-03-10
9:12 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
780$210.6540,985
(Direct)
View
2020-03-09
Exercise
2020-03-10
9:12 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
1,480$58.4340,985
(Direct)
View
2020-03-03
Option Award
2020-03-05
7:58 pm
N/A
N/A
AMGEN INCAMGNREESE DAVID M
EVP, Research and Development
3,711$040,285
(Direct)
View